{
  "company": {
    "name": "Noema Pharma",
    "website": "https://noemapharma.com/",
    "record": "https://startuphistory.org/c/noemapharma.com"
  },
  "status": null,
  "history_since": "2020-12-01T14:58:14.000Z",
  "baseline": {
    "snapshot_id": "e3112dfcd57a611293a6f30d5fea14852ec4d73d32dfa0e7dc91401aff59f1d9",
    "observed_at": "2020-12-01T14:58:14.000Z",
    "headline": "BEYOND SYMPTOM CONTROL",
    "description": null,
    "evidence": "https://web.archive.org/web/20201201145814/https://noemapharma.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-06T17:49:46.599Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2025-07-09T19:52:05.000Z",
      "variants": [
        {
          "headline": "BEYOND SYMPTOM CONTROL",
          "subhead": null,
          "observed_at": "2020-12-01T14:58:14.000Z",
          "evidence": "https://web.archive.org/web/20201201145814/https://noemapharma.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "BEYOND SYMPTOM CONTROL",
          "subhead": null,
          "observed_at": "2021-03-05T00:24:25.000Z",
          "evidence": "https://web.archive.org/web/20210305002425/https://noemapharma.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "BEYOND SYMPTOM CONTROL",
          "subhead": "BEYOND SYMPTOM CONTROL Developing therapies to restore functioning in patients with orphan conditions of the brain and nervous system, so that they can live their lives to the fullest Who We Are Noema",
          "observed_at": "2021-07-25T02:17:14.000Z",
          "evidence": "https://web.archive.org/web/20210725021714/https://noemapharma.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "BEYOND SYMPTOM CONTROL",
          "subhead": "BEYOND SYMPTOM CONTROL Developing therapies to help both orphan and larger patient populations with conditions of the brain and nervous system live their lives to the fullest. Who We Are Noema Pharma ",
          "observed_at": "2022-08-16T12:40:02.000Z",
          "evidence": "https://web.archive.org/web/20220816124002/https://noemapharma.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "BEYOND SYMPTOM CONTROL",
          "subhead": "BEYOND SYMPTOM CONTROL Developing therapies to help both orphan and larger patient populations with conditions of the brain and nervous system live their li...",
          "observed_at": "2023-02-02T01:05:51.000Z",
          "evidence": "https://web.archive.org/web/20230202010551/https://noemapharma.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "BEYOND SYMPTOM CONTROL",
          "subhead": "BEYOND SYMPTOM CONTROL Developing therapies to help both orphan and larger patient populations with conditions of the brain and nervous system live their li...",
          "observed_at": "2023-08-08T02:07:59.000Z",
          "evidence": "https://web.archive.org/web/20230808020759/https://noemapharma.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "BEYOND SYMPTOM CONTROL",
          "subhead": "BEYOND SYMPTOM CONTROL Developing therapies to help both orphan and larger patient populations with conditions of the brain and nervous system live their li...",
          "observed_at": "2024-01-04T10:10:58.000Z",
          "evidence": "https://web.archive.org/web/20240104101058/https://noemapharma.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "BEYOND SYMPTOM CONTROL",
          "subhead": "BEYOND SYMPTOM CONTROL Developing therapies to help both orphan and larger patient populations with conditions of the brain and nervous system live their li...",
          "observed_at": "2025-01-06T19:13:54.000Z",
          "evidence": "https://web.archive.org/web/20250106191354/https://noemapharma.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "BEYOND SYMPTOM CONTROL",
          "subhead": "BEYOND SYMPTOM CONTROL Developing therapies to help both orphan and larger patient populations with conditions of the brain and nervous system live their li...",
          "observed_at": "2025-07-09T19:52:05.000Z",
          "evidence": "https://web.archive.org/web/20250709195205/https://noemapharma.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "BEYOND SYMPTOM CONTROL",
      "subhead": "BEYOND SYMPTOM CONTROL Developing therapies to help both orphan and larger patient populations with conditions of the brain and nervous system live their li...",
      "from": "2020-12-01T14:58:14.000Z",
      "to": "2025-07-09T19:52:05.000Z",
      "captures": 9,
      "evidence": "https://web.archive.org/web/20250709195205/https://noemapharma.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2020-12-01T14:58:14.000Z",
          "to": "2025-07-09T19:52:05.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-06T17:49:46.599Z",
      "variants": [
        {
          "headline": "DRIVING BETTER OUTCOMES",
          "subhead": "DRIVING BETTER OUTCOMES Advancing therapeutics designed to deliver superior clinical benefit across both orphan and broader neurology indications Who we are...",
          "observed_at": "2026-01-14T16:17:56.000Z",
          "evidence": "https://web.archive.org/web/20260114161756/https://noemapharma.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "DRIVING BETTER OUTCOMES",
          "subhead": "DRIVING BETTER OUTCOMES Advancing therapeutics designed to deliver superior clinical benefit across both orphan and broader neurology indications Who we are...",
          "observed_at": "2026-11-06T17:49:46.599Z",
          "evidence": "https://noemapharma.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "DRIVING BETTER OUTCOMES",
      "subhead": "DRIVING BETTER OUTCOMES Advancing therapeutics designed to deliver superior clinical benefit across both orphan and broader neurology indications Who we are...",
      "from": "2026-01-14T16:17:56.000Z",
      "to": "2026-11-06T17:49:46.599Z",
      "captures": 2,
      "evidence": "https://noemapharma.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2026-01-14T16:17:56.000Z",
          "to": "2026-11-06T17:49:46.599Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-e3112dfcd57a611293a6f30d5fea14852ec4d73d32dfa0e7dc91401aff59f1d9:d2d4368f4e8f0e5258e9a40457ca54f2b81b7b340e46c015db884670e339560a:funding:5dbf30e46ed316d1",
      "before_evidence": "https://web.archive.org/web/20201201145814/https://noemapharma.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "funding",
      "label": "Funding",
      "summary": "Announced on its homepage: “INVESTORS The Noema team successfully raised a 54 million Swiss Franc (USD59 million/EUR50 million) Series A financing round co-led by So…”.",
      "between": {
        "from": "2020-12-01T14:58:14.000Z",
        "to": "2021-03-05T00:24:25.000Z"
      },
      "evidence": "https://web.archive.org/web/20210305002425/https://noemapharma.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/announced-funding"
    },
    {
      "n": 2,
      "id": "page-4737298dd7a27bb3377b1f93e6bafc7231fc51734c4c39a13749c8b6b02b4670:1c1f0e8958f9374790253eb09617bedb58d525a9387179d9094aab9647d6438a:hiring:20dd4c09cc4ab0aa",
      "before_evidence": "https://web.archive.org/web/20210725021714/https://noemapharma.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "hiring",
      "label": "Hiring",
      "summary": "Added a careers page.",
      "between": {
        "from": "2021-07-25T02:17:14.000Z",
        "to": "2022-08-16T12:40:02.000Z"
      },
      "evidence": "https://web.archive.org/web/20220816124002/https://noemapharma.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-careers-page"
    },
    {
      "n": 3,
      "id": "page-1f08e0673bb9796db6aef2b20bbfdf1c727265ba30eca76b1b71c3117d0dfe55:8a41efa166e0a3b869665246b0100854a96cfdae3a56edacaa69f0a82dfb2568:headline:82b4585a18f26ed3",
      "before_evidence": "https://web.archive.org/web/20250709195205/https://noemapharma.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “BEYOND SYMPTOM CONTROL” to “DRIVING BETTER OUTCOMES”.",
      "between": {
        "from": "2025-07-09T19:52:05.000Z",
        "to": "2026-01-14T16:17:56.000Z"
      },
      "evidence": "https://web.archive.org/web/20260114161756/https://noemapharma.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Noema Pharma” company record, https://startuphistory.org/c/noemapharma.com"
}